Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 225,14 € (+11,02 %). La mediana es de 226,56 € (+11,72 %).
| Comprar |
25 |
| Mantener |
10 |
| Vender |
0 |
Noticias Ir al feed de noticias
Welltower posts 15th consecutive quarter of 20%+ NOI growth and raises 2026 guidance
Welltower reported SHO same-store NOI growth of 20.5% with occupancy up to 89.4% and raised 2026 normalized FFO guidance to $6.36–$6.44 per share. Management closed large acquisitions and highlighted sustained private-pay demand as the baby boomer aging wave outpaces new senior housing supply. The REIT boosted its quarterly dividend and maintains low leverage, positioning it as the sector-scale compounder amid strong operating momentum. » Más en finance.yahoo.com
Welltower reports strong revenues, stock falls after missed FFO and profit-taking
Welltower beat expectations with revenue of $3.54 billion but missed adjusted FFO at $1.60 per share versus roughly $1.66 estimated. Management raised the full-year FFO guidance and increased the quarterly dividend by about 14.9% to $0.85 per share. After a strong premarket rally and amid a weaker overall market, profit-taking during the conference call led the stock to fall roughly 1.6% intraday. UBS reiterates a buy rating with a $271 price target, citing accelerated FFO and NOI growth in the senior housing segment. » Más en de.investing.com
Welltower posts surge in revenue and hits record high after price-target increases
Welltower reported Q2 2026 revenue of $3.54 billion, comfortably beating the consensus estimate of $3.36 billion — a 39.1% increase year over year. Normalized FFO were $1.60 per diluted share, slightly below estimates of $1.66. Analysts subsequently raised price targets (Mizuho: $239 → $260; UBS previously at $271) and the stock rose 4.3% in after-hours trading to $258.95, surpassing its 52-week high. The senior housing portfolio remains the main growth driver, benefiting from an aging population and limited new supply. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | junio de 2026 | |
|---|---|---|
| Ingresos | 3105,8 M | 45,49 % |
| Beneficio bruto | 1221,84 M | 43,81 % |
| Beneficio neto | 210,55 M | 17,80 % |
| EBITDA | 1162,74 M | 44,61 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 147,29 mil M € |
Número de acciones | 720,57 M |
Máximo/mínimo de 52 semanas | 222,37 € - 142,69 € |
Rentabilidad por dividendo | 1,29 % |
Dividendos TTM | 2,64 € |
Beta | 0,76 |
Ratio P/E | 121,55 |
Ratio PEG | 15,54 |
Ratio P/B | 3,56 |
Ratio P/S | 13,40 |
Perfil de la empresa
Welltower Inc. (NYSE:WELL), ein S&P 500-Unternehmen mit Hauptsitz in Toledo, Ohio, treibt den Wandel der Infrastruktur im Gesundheitswesen voran. Das Unternehmen investiert mit führenden Betreibern von Seniorenwohnungen, Anbietern von Post-Akut-Kliniken und Gesundheitssystemen, um die Immobilieninfrastruktur zu finanzieren, die für die Skalierung innovativer Versorgungsmodelle und die Verbesserung des Wohlbefindens der Menschen und der gesamten Gesundheitsversorgung erforderlich ist. Welltower™, ein Real Estate Investment Trust ("REIT"), besitzt Beteiligungen an Immobilien, die sich auf wichtige, wachstumsstarke Märkte in den Vereinigten Staaten, Kanada und Großbritannien konzentrieren und aus Seniorenwohnungen, postakuten Gemeinschaften und ambulanten medizinischen Einrichtungen bestehen.
| Nombre | Welltower |
| CEO | Shankh S. Mitra |
| Sede | Toledo,
oh Estados Unidos |
| Sitio web | |
| Sector | Inmobiliario |
| Industria | REITs sanitarios |
| Salida a bolsa | 19/03/1980 |
| Empleados | 712 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NYSE | WELL |
London Stock Exchange | 0LUS.L |
Frankfurt | HCW.F |
Düsseldorf | HCW.DU |
London | 0LUS.L |
SIX | HCW.SW |
München | HCW.MU |